TheWell Bioscience is excited for Hera BioLabs to be presenting at AALAS 2022. Dr. Fallon Noto, Ph.D., Executive Director R&D/ In Vivo services will be presenting VitroGel® data at the in-person presentation “Husbandry Guidelines & Xenograft Processes for the SRG Rat” on Monday, October 24th at 2:15 PM EDT in Louisville, KY. This talk will […]
TheWell Bioscience is excited to be exhibiting at ISSCR 2022 (International Society for Stem Cell Research) on June 15-11 in San Francisco, CA. Stop by booth# 541 to learn about our VitroGel®, our robust, scalable, xeno-free line of hydrogels for: Organoids | Stem Cells | MSCs | Cancer Spheroids | Invasion Assay | Co-Culture | […]
TheWell Bioscience is excited to be exhibiting at AACR 2022 (American Association for Cancer Research) on April 10-13 in New Orleans, LA. Stop by booth# 1244 to learn about our VitroGel®, our robust, scalable, xeno-free line of hydrogels for: Organoids | Stem Cells | MSCs | Cancer Spheroids | Invasion Assay | Co-Culture | Angiogenesis […]
TheWell Bioscience is excited to be exhibiting at SLAS (Society for Laboratory Automation and Screening) 2022 this coming Feb 7-9 in Boston, MA. Stop by booth# 2440 to learn about our VitroGel®, our robust, scalable, xeno-free line of hydrogels for: Organoids | Stem Cells | MSCs | Cancer Spheroids | Invasion Assay | Co-Culture | […]
We are excited that our VitroGel®, a xeno-free hydrogel system, is part of the National Institute of Standards and Technology’s (NIST) goal to establish a standard for measuring cell viability in manufactured tissues. For more information on the project visit https://www.nist.gov/mml/bbd/biomaterials/measuring-cell-viability-scaffolds
GHP Magazine has Announced the Winners of the 2020 Healthcare & Pharmaceutical Awards Excited to be awarded Global Health Pharma’s 2020 Healthcare & Pharmaceutical Awards as the Most Innovative 3D Hydrogel System. Click to read the article.
Proud to be recognized as one of the “8 Top 3D Bioprinting Startups in Biotech”. 8 Top 3D Bioprinting Startups Impacting The BioTech Industry
We are excited to be a part of the ARMI BioFabUSA program. We look forward to the collaborations to help ARMI’s mission to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. “TheWell Bioscience Inc., a New Jersey biotech company focused on 3D cell culture, […]
North Brunswick, NJ., January 16, 2020 – TheWell Bioscience Inc, a biotech company focusing on 3D cell culture, launches VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking. The new bioinks are ready-to-use at room temperature, have excellent visibility after printing, and can incorporate multiple […]
Excited to produce our first batch of our VitroINK RGD for pre-order. These new generations of bioinks are READY-TO-USE. No UV No Heat Curing No Chemical Cross-linking If your facility needs a new generation of bioinks that is easier to use, please contact us.
